Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT01566175
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Registry
-
NCT01566175
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Israel
- Registry status
- Recruiting
Technical summary
Registry record NCT01566175. Allocation not applicable; no masking; primary purpose treatment. Start 2011-08-30 (actual); primary completion 2030-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization
- Acronym
- Reducer
- Condition
- Refractory Angina
- Intervention (Device)
- Neovac coronary sinus reducer
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Collaborator
- Shockwave Medical, Inc.
Record details
- Record id
cardio:ct-nct01566175- Content hash
1f2accefee7bbae698afe0b2a167d1177fd3f1e8c5b0428fffb042ee238b777a